Evidence for Intravenous Ketamine as Adjunct Perioperative Analgesia - Matt Fisher, MD
Upon completion of this activity, the learner will be able to:
- Recite clinically applicable mechanisms of ketamine as it pertains to acute pain, chronic pain, and mood.
- Identify surgical and patient characteristics that are likely to realize marginal benefit from perioperative ketamine administration based on results from blinded randomized controlled trials
- Determine dosing strategies grounded in literature for use of perioperative ketamine in light of patient and surgical factors.
Matt Fisher, MD
Michael Perouansky, MD
|Kylie Van Esss|
It is the policy of the University of Wisconsin–Madison ICEP that the faculty, authors, planners, and other persons who may influence content of this CE activity disclose all relevant financial relationships with commercial interests* in order to allow CE staff to identify and resolve any potential conflicts of interest. Faculty must also disclose any planned discussions of unlabeled/unapproved uses of drugs or devices during the educational activity. For this educational activity all conflicts of interests have been resolved and detailed disclosures are listed below:
Matt Fisher, MD: No relevant relationships to disclose in regard to this activity.
Michael Perouansky, MD: No relevant relationships to disclose in regard to this activity.
Kylie Van Ess: No relevant relationships to disclose in regard to this activity.
Jessica Carlucci-Jenkins, BA: No relevant relationships to disclose in regard to this activity.
Kim Sprecker: No relevant relationships to disclose in regard to this activity.
* The ACCME defines a commercial interest as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. The ACCME does not consider providers of clinical service directly to patients to be commercial interests.
Disclosure of Unlabeled Use: The University of Wisconsin–Madison ICEP advises the participant that this continuing medical education activity may contain reference(s) to unlabeled or unapproved uses of drugs or devices
|In support of improving patient care, the University of Wisconsin–Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.|
Credit Designation Statements
American Medical Association
The University of Wisconsin–Madison ICEP designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Continuing Education Units
The University of Wisconsin–Madison, as a member of the University Continuing Education Association (UCEA), authorizes this program for 0.1 continuing education units (CEUs) or 1 hour.
- 1.00 AMA PRA Category 1 Credit™
- 1.00 University of Wisconsin–Madison Continuing Education Hours